AKT1 and breast carcinoma: Additionally, in breast cancer, activating the human epidermal growth factor receptor 2-RAC-alpha serine/threonine protein kinase (HER2-AKT1) axis inhibits cGAS and TBK1 enzymatic activity [56,195].